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Background: Gas trapping suggesting small airway disease is observed in adult asthmatic
suffering from severe asthma. The aim of the study was to assess whether gas trapping could
be evidenced in asthmatic children with/without severe exacerbation and with/without symp-
toms during the past three months.
Methods and patients: Forced expiratory flows (FEV1, FVC, MEF25e75%, MEF50%), plethysmo-
graphic lung volumes (TLC, FRC, RV) before and after bronchodilation (BD) were recorded in
asthmatic children with documented airflow reversibility. Three groups were defined according
to the presence during the last three months of 1) severe exacerbation (oral steroid: 3 consec-
utive days) 2) asthma symptoms without severe exacerbation and 3) without any symptom
(GINA guidelines).
Results: 180 children (median 11.3 years, range 6.3e17.6, 57 girls) were included, 24 (13%) had
at least one severe exacerbation, 58 (33%) had respiratory symptoms without severe exacerba-
tion and 98 (54%) had no symptom during the past 3 months. Forced expiratory flows did not
significantly differ in these three groups, while RV/TLC was significantly higher in the first
group before and even after bronchodilation: before BD, 0.27  0.07, 0.24  0.05 and
0.23  0.05, respectively (p Z 0.016) and after BD, 0.25  0.07, 0.21  0.05, 0.21  0.05,
respectively (p Z 0.003).Physiologie e Clinique de la Dyspne´e, Hoˆpital Europe´en Georges Pompidou, 20, rue Leblanc, 75015
.
x@egp.aphp.fr (C. Delclaux).
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erbation during the last three months, suggesting a small airway disease that is not evidenced
by forced expiratory flows.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
While studies have demonstrated that abnormalities of lung
volumes (gas trapping) can be present in asymptomatic
asthmatic children with normal spirometry,1,2 systematic
measurement of lung volumes is not recommended in
current guidelines even in the more severe patients.
Whether these abnormalities are associated with delete-
rious clinical or functional outcomes in children remains
largely unknown, which may explain the absence of formal
recommendation. Recently Sorkness and colleagues showed
that severe asthma in adults is associated with lung
hyperinflation3 that deserves to be demonstrated in chil-
dren since a normal lung function is considered as rule in
childhood.4 Overall, one may hypothesize that both
uncontrolled symptoms and exacerbations may be associ-
ated with functional abnormalities. Consequently, the aim
of our cross-sectional study was to assess whether asthma
symptoms and/or severe exacerbation in the past three
months were associated with functional abnormalities
while the children were asymptomatic for one week at the
time of assessment. To further evaluate whether the
abnormalities are related to the persistence of increased
bronchomotor tone and/or remodelling process, broncho-
dilator response was systematically tested.
Methods
All consecutive children suffering from asthma (diagnosis
criteria of GINA guidelines: www.ginasthma.com) with
a previously documented reversibility (>12% increase in
FEV1 or 50% decrease in sRaw) were studied in a period of
disease stability (absence of any respiratory symptom over
the last week) between December 1, 2008 and November
30, 2009. The study was approved by the Institutional
Review Board of the French Language society for respira-
tory medicine e Socie´te´ de Pneumologie de Langue Fran-
c¸aise, and children/parents gave their consent.
Due to the retrospective assessment of clinical events,
the time interval to be chosen needed to allow accurate
recall of symptoms and to be sufficient for severe exacer-
bation exposure. We chosen a three-month time-lag since
this time interval is sufficient to isolate asthmatic patients
with frequent exacerbations as suggested by Miller and
colleagues.5 Consequently, the following indices were
recorded for the past three months: 1) duration of oral
steroid treatment reported in the health record (a severe
exacerbation was defined by an exacerbation requiring at
least three days of systemic corticosteroid treatment), 2)
number of days with symptoms (those defined in GINA
guidelines for asthma control) assessed by parents, and 3)
mean dose of ICS (given as beclomethasone equipotent
daily dose as defined in GINA guidelines).Bronchodilator treatment was withheld for 12 h before
pulmonary function tests. Spirometry and body plethys-
mography (MasterScreen Body, Jaeger, Wu¨rtzburg,
Germany) were performed as previously described,1,6
according to international recommendations. A systematic
assessment of the bronchodilator response (salbutamol,
400 mg) was performed. Special attention was ensured to
obtained maximal expiratory effort for residual volume
(RV) measurement. Reference values were those recom-
mended by Stocks and Quanjer.7
We calculated that over one year the inclusion of 180
children would ensure a severe exacerbation group >20
children (540 months of follow-up with an exacerbation
rate of 0.50/patient/year). Variables were expressed as
mean  SD, except when stated. The statistical tests used
are detailed in the results. A two-tailed P value below 0.05
was considered statistically significant. Statistical analyses
were performed using Statview and MedCalc softwares.
Results
Twenty-four children (13%) experienced at least one severe
exacerbation, 58 (32%) had only mild respiratory symptoms
and 98 (54%) had no respiratory symptom during the past
three months. Their clinical and functional characteristics
are described in Table 1. No difference in gender, age and
atopic status was found between these three groups, while
children with a severe exacerbation differed from the two
other groups by a higher ICS treatment dose. Their
pulmonary function tests show that gas trapping is evi-
denced in the children who experienced a severe exacer-
bation. Using receivereoperator characteristic curve
analysis, a (RV/TLC)Pre-BD greater than 0.30 was the best
threshold to identify these children (p Z 0.022, AUC 0.65;
95% CI [0.57e0.72]), with a high specificity (92%) but a low
sensitivity (38%).
Discussion
The main result of our study is the demonstration that
a severe exacerbation within the previous three months is
associated with subsequent gas trapping suggesting a small
airway disease that is not evidenced by forced expiratory
flows in asthmatic children. Our study emphasizes that lung
volume measurement is probably a useful tool in asthmatic
children because it has become increasingly clear that
children at all levels of asthma severity can have relatively
unimpaired FEV1 values when clinically stable.
4 It has to be
stated that lung volume abnormalities evidenced (isolated
increase in residual volume) are mild, but the increase in
RV in obstruction is deemed to be a marker of airway
closure as stated in the ATS/ERS Task Force guidelines.8
Lung volume assessment is not a routine test in several
Table 1 Characteristics of the three groups of asthmatic children.
Severe
exacerbation n Z 24
Mild
symptoms n Z 58
No
symptoms n Z 98
P valuesa
Gender, girls/boys 10/14 20/38 27/71 0.35
Age, years: median [range] 10.8 [6.9e16.5] 11.7 [7.3e17.1] 11.6 [6.3e17.6] 0.18
Height, cm 143  13 150  14 149  14 0.09
Weight, kg 38  12 44  15 42  13 0.22
Skin prick tests 0.96
One positive test, n 4 12 24
More than one, n 17 38 58
Negative, n 2 6 11
Non available, n 1 2 5
Treatment
ICS GINA categories, high/moderate/low/no ICS 7/8/5/4 6/14/24/14 10/24/26/38 0.026
ICS dose e BED, (mg/d) 357  256 248  271 202  222 0.020
LABA, n 20 40 59 0.20
LRA, n 0 1 3 0.63
Severe exacerbation n Z 24 Mild symptoms n Z 58 No symptoms n Z 98 P valuesa
Pre-BD Post-BD Pre-BD Post-BD Pre-BD Post-BD Pre-BD Post-BD
Spirometry
FEV1 (% pred) Zapletal 94  15 105  13 96  12 108  10 98  15 107  12 0.53 0.59
FEV1 (% pred) Quanjer 90  15 100  12 92  11 103  11 93  11 103  11 0.46 0.47
FEV1/VC (%) 77  9 84  8 75  7 82  6 76  7 83  7 0.54 0.63
FVC (% pred) Zapletal 103  15 105  13 106  13 108  10 106  12 108  13 0.58 0.59
FVC (% pred) Quanjer 101  14 103  13 105  13 107  11 104  11 106  11 0.38 0.28
FEF25e75% (% pred) Zapletal 71  23 91  26 68  18 88  16 69  16 89  18 0.77 0.75
FEF50% (% pred) Zapletal 69  21 92  24 68  17 89  15 69  15 88  17 0.91 0.70
Plethysmography
sRaw, kPa s 0.96  0.24 0.61  0.15 1.09  0.32 0.63  0.14 1.03  0.25 0.63  0.15 0.13 0.81
TLC, % pred 105  15 103  14 106  10 104  10 105  10 103  10 0.84 0.14
FRC, % pred 102  19 98  19 104  18 100  15 105  14 102  15 0.63 0.96
RV, % pred 116  42 106  42 105  31 93  20 101  25 91  23 0.076 0.044
FRC/TLC 0.47  0.06 0.47  0.06 0.48  0.06 0.47  0.05 0.49  0.05 0.48  0.06 0.22 0.37
RV/TLC 0.27  0.07 0.25  0.07 0.24  0.06 0.21  0.05 0.23  0.05 0.21  0.05 0.016 0.003
BD denotes bronchodilator; ICS denotes inhaled corticosteroid; LABA denotes Long-acting beta-agonist; LRA denotes leukotriene
receptor antagonist; BED denotes beclomethasone equipotent dose.
Results are expressed as mean  SD, except when stated.
P values in bold are statistically significant.
a ANOVA or chi-2 test between the three groups (tested before [pre-BD] and after [post-BD] bronchodilation).
1232 B. Mahut et al.centers. For instance, Sorkness and colleagues described
a large sample of severe asthmatic patients, but only 84/
287 had lung volume measurements.3 We and others
previously demonstrated that gas trapping can be demon-
strated in asthmatic children with normal forced expiratory
flows.1,2 In this study, we further show that gas trapping is
more pronounced in children with a history of severe
exacerbation in the past three months (high specificity but
low sensitivity for the RV/TLC ratio). The practical conse-
quence is that when a child exhibits an RV/TLC ratio before
bronchodilation above 0.30, it can confidently be explained
by an exacerbation in the previous three months.
Our study has inherent limitations due to its cross-
sectional design and due to the retrospective assessment of
clinical events. Weng and Levison studied a group of asth-
matic children from acute attack to symptom free status and
noted that abnormalities of static lung volumes were
common in the interval phase,9 consequentlywecannot inferfrom our results that the observed abnormalities will persist.
But one may hypothesize that the repetition of severe
exacerbations will lead to a definitive loss of function.10
In conclusion, gas trapping is associated with occurrence
of a severe exacerbation during the last three months in
asthmatic children, suggesting a small airway disease that
is not evidenced by forced expiratory flows.Conflict of interest
The authors declare no conflict of interest.
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